With a view to the diversification of medical software applications worldwide, Dr. Bing-fei Wu (吳炳飛), Chair Professor of Yang Ming Chiao Tung University, led a team of students to develop a software technology solution for "image recognition of physiological signals and AI learning technology", providing users with zero-touch access to physiological information such as heart rate, blood pressure, blood oxygen, etc. The company has received more than $200 million in Series A funding from Taiwan Capital, Mega International Commercial Bank, Abico Group and Shanghai Commercial and Savings Bank.

The team aims to develop FaceHeart Vitals solutions that can be used in different platforms and contexts with a global market in mind, hoping to establish a new perspective for Taiwan's technology industry with AI software and encourage the technology industry to nurture more international software talents.

FaceHeart's General Manager Mr.Chang said that they have developed the FaceHeart Vitals solution by using a video-based non-contact rPPG remote optoelectronic capacitive pulse wave signal technology and AI learning model. It is expected to pass the first stage of FDA medical software certification early next year.

The FaceHeart Vitals solution is offered as a Software Development Kit (SDK) with a camera and display hardware terminal to develop a variety of health management applications, and has been introduced to healthcare solutions in collaboration with Yitian Kuyo and has also partnered with NUWA to develop a healthcare robot NUWA.

In clinical trials, FaceHeart has worked with the cardiology departments of NTU, Chang Gung, Enjou and Yungtung hospitals, testing over 3,000 people and obtaining 100 million pieces of data. Through clinical diagnosis by doctors and AI learning optimization, FaceHeart has developed integrated solutions for remote monitoring of "irregular heart rate - atrial fibrillation", "sleep apnea" and "continuous blood pressure" in users' homes.

FaceHeart completed a Series A round of funding of $210 million in July this year, led by Taiwan Capital, and with other investors including Mega International Commercial Bank, Abico Group and Shanghai Commercial and Savings Bank.

More information please visit www.faceheart.com